-
-
-
-
-
-
-
Akcea Therapeutics (AKCA), Ionis Pharmaceuticals, Inc. (IONS) Present Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx)
-
-
-
-
-
-
-
Ionis reports second quarter 2020 financial results and recent business achievements
-
-
-
-
-
-
-
Akcea Therapeutics (AKCA) Announces Appointment of New Chief Medical Officer
-
-
-
-
-
-
-
Akcea (AKCA) announces approval for reimbursement of TEGSEDI in Portugal for treatment of hereditary transthyretin amyloidosis with polyneuropathy
-
-
-
-
-
-
-
Akcea Therapeutics (AKCA) Announces Approval for Reimbursement of TEGSEDI in Spain for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
-
-
-
-
-
-
-
Ionis provides fourth quarter and full year 2019 financial results
-
-
-
-
-
-
-
Akcea Therapeutics (AKCA) Tops Q3 EPS by 13c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

